Dysregulation of SIRT1 is associated with a variety of diseases including metabolic disorders, neurodegenerative diseases, and cardiovascular diseases. For example, reduced SIRT1 activity has been linked to insulin resistance and type 2 diabetes. In the context of neurodegenerative diseases, SIRT1 activation has been shown to protect against neuronal damage in models of Alzheimer's and Parkinson's diseases.
